Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis.

Chenghua Weng,Leixi Xue,Qing Wang,Wentian Lu,Jiajun Xu,Zhichun Liu

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis.

2021

Chenghua Weng
Leixi Xue
Qing Wang
Wentian Lu
Jiajun Xu
Zhichun Liu

Objective:To evaluate the comparative efficacy and safety of Janus kinase (JAK) inhibitors and biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) ...

Keywords:

Internal medicine
Medicine
Antirheumatic drugs
Oncology
Disease
Janus kinase
Rheumatoid arthritis
in patient
Meta-analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations